Alnylam Begins Phase 1 Clincial Trial For ALN-AS! By: Benzinga via Benzinga May 26, 2015 at 08:02 AM EDT Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has initiated a Phase 1 ... Read More >> Related Stocks: Alnylam Pharmaceuticals